Skip to main content
Caplight Logo









Partex

Partex

Private
EschbornHealthcare & Life Scienceshttps://partex.ai/en

Last Round

Series C

Apr 25, 2019

Total Funding Raised

$3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Partex is a biotechnology company that develops an advanced artificial intelligence and blockchain technology platform designed to support all stages of drug development from pipeline to market.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Subscription SaaS, Marketplace Commission, Freemium

AI Layer

Application

Keywords

AI drug discoverydrug repositioningdrug repurposingtechbioAI biotechcomputational drug discoverytherapeutic asset managementin silico drug discoveryclinical success predictionADMET predictiondrug licensing platformdrug asset exchangepredictive toxicologyde-novo molecular designAI research assistantwet lab validation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Partex Comparables

Compare Partex with similar companies based on industry and business-model similarity.

Partex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Delta4
81%
Healx
79%
Insilico Medicine
79%

Partex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CApr 25, 2019
Pre SeedDec 22, 2016

Key People

Founding team and executive leadership

Gaurav Tripathi

Co-Founder & Group CTO

Founding Team

Partex Investors

Notable investors and investment history

Partex investors
InvestorRounds
Block.oneSeries C
HCS BeteiligungsgesellschaftPre Seed
Heliad AGSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 22, 2026

    Open roles increased to 30, 2.3x the trailing average.

  • Dec 7, 2025

    Monthly visitors grew 95% MoM, reaching 6.7K.

Partex Filings

Explore SEC and related filing metadata, where available.

Partex filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Partex's valuation, stock price, and market status.

Is Partex a public or private company?

Partex is a private company.

What is the current stock price of Partex?

Partex is a private company with no public stock price. No recent secondary market data is available.

How much is Partex worth (valuation)?

Valuation information for Partex is not publicly available.

Can I buy Partex stock?

Partex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Partex's last funding round?

Partex's most recent funding round was Series C on April 25, 2019.

Who are the main investors in Partex?

Key investors in Partex include HCS Beteiligungsgesellschaft, Heliad AG.

Will Partex IPO soon?

No public IPO plans have been announced for Partex.

How can I track Partex secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Partex's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEschborn
Employee Range182
Year Founded2011
Last FundingApr 25, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?